ロード中...
Binary surrogate endpoints in clinical trials from the perspective of case definitions
INTRODUCTION: Surrogate endpoints are widely used in clinical trials, especially in situations where the endpoint of interest is not directly observable or to avoid long trial periods. A typical example for this case is frequently found in clinical trials in oncology, where overall survival (OS) as...
保存先:
| 出版年: | Eur J Microbiol Immunol (Bp) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Akadémiai Kiadó
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8042653/ https://ncbi.nlm.nih.gov/pubmed/33666567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1556/1886.2020.00031 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|